Clinical Research Finds a Cure for Time Zones

Actelion Pharmaceuticals Ltd did its research. And found a way to save vital time and money during clinical trials on the things that make us healthy. 


6 August 2014

Clinical Research Finds a Cure for Time Zones

Actelion Pharmaceuticals Ltd did its research. And found a way to save vital time and money during clinical trials on the things that make us healthy.

In the life sciences field, the words “clinical trials” and “simple” are seldom used together.

Testing biopharmaceuticals, such as those developed by Actelion Pharmaceuticals Ltd for illnesses such as pulmonary arterial hypertension (PAH), is an incredibly complex undertaking.

For the Switzerland-based company, launching and conducting these trials requires a constant exchange of highly sensitive reports between a huge network of Clinical Research Associates (CRAs), investigators, trial sponsors, and monitors working among the 40 countries and global study sites it reaches.

Not an easy task. Especially when the industry norm is overnighting documents via courier — or attempting to email big files to large groups of colleagues without adequate security.

Actelion needed to innovate on the old methods. The company wanted to create an online clinical trial portal where colleagues in any time zone could find the information they needed, any time of day, securely.

The portal, Intralinks Studyspace™, lets them eliminate the costly travel for training CRAs, by doing it all through their platform instead.

The move cured the clinical trial blues. Actelion saved €3,000 for every Suspected Unexpected Serious Adverse Reaction (SUSAR) report sent to field sites.

“Intralinks offered us a secure portal where our people can pull information whenever they need it, no matter what time zone they are in,” says Christine Schwenninger, head of Actelion’s Global Monitoring Group.

Actelion also used Intralinks Studyspace to start four clinical trials, with a fifth in the works.

The prognosis? Intralinks will keep making a huge impact for Actelion and its research toward a healthier world.

Want to learn more? Get the details here.



Andrew Mitchell

Andrew Mitchell

Andrew Mitchell is the director of strategy and product marketing for life sciences at Intralinks. Andrew has many years of experience working in and with the Life Sciences industry, delivering innovative software solutions through his time with Covance, Relsys, Medidata and BioPharm Systems (Oracle Gold implementation partner). With a focus on Software as a Service, he has a strong belief in providing solutions that simplify and improve the user experience and the relevant subject matter expertise to ensure delivery of real benefits and enhanced compliance.